BEUDAMED
    FDA Adverse Event Injury Summary report: N

    MUGARD ORAL RINSE 240 ML/BTL

    MDR report key: 19744099 · Received July 12, 2024

    Report

    Report Number
    MW5157264
    Event Type
    Injury
    Date Received
    July 12, 2024
    Report Date
    July 10, 2024
    Manufacturer
    SOLEVA PHARMA LLC
    Product Code
    MGQ
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    PA, US
    Reporter Occupation
    OTHER HEALTH CARE PROFESSIONAL
    Health Professional
    Yes

    Narratives

    Description of Event or Problem · 0

    EVENT: PATIENT STATES HE NOW HAS LIVER CANCER. FREQ: SWITCH AND EXPEL OR SWALLOW 5-10 ML 4-6 TIMES DAILY AS PRESCRIBED FOR THE MANAGEMENT OF ORAL MUCOSITIS.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    738553 MUGARD ORAL RINSE 240 ML/BTL DRESSING, WOUND AND BURN, HYDROGEL W/DRUG AND/OR BIOLOGIC MGQ SOLEVA PHARMA LLC

    Patients

    Seq Age Sex Outcome Treatment
    1 NA Male Other CEPHALEXIN | DOXYCYCLINE POW MONOHYDR| ELIQUIS TAB 5MG| HYDROCOD / IBU TAB 7.5-200| ONDANSETRON TAB 4MG| PROTONIX TAB 20MG